Breast Cancer Drug Recommended to be Pulled

By: Ashton King Email
By: Ashton King Email

A panel of experts recommends the FDA withdraw Avastin as a breast cancer fighting drug.

Avastin went on the market in 2008 after a trial showed it delayed breast cancer symptoms, but a follow-up study couldn't replicate the results.

The FDA, however, doesn't always follow the panel's advice.

You must be logged in to post comments.

Password (case sensitive):
Remember Me:
WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 98906754 -
Gray Television, Inc.